Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Dapagliflozin (10mg) + Metformin (500mg) + Vildagliptin (100mg) Tablet
Therapeutic Category
Antidiabetic, Diabetic, Endocrinology
Dosage Form
Tablet
Packaging Type
Alu Alu
Packaging
10*10
Price
₹229/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Dapagliflozin 10mg + Metformin 500mg SR + Vildagliptin 100mg Tablet is a triple-combination oral anti-diabetic formulation used for the treatment of type 2 diabetes mellitus in patients requiring improved glycemic control.
This combination works through complementary mechanisms—dapagliflozin reduces glucose reabsorption via the kidneys, metformin improves insulin sensitivity and reduces hepatic glucose production, while vildagliptin enhances incretin activity to regulate insulin secretion.
Clinically, it is prescribed for patients with uncontrolled blood glucose levels, helping manage fasting and postprandial glucose while reducing the risk of long-term diabetic complications.
With rising diabetes prevalence and strong demand for fixed-dose combinations, this formulation supports consistent prescriptions, enhances portfolio strength, and helps attract long-term associations through effective, comprehensive glucose management solutions.
Common side effects may include nausea, diarrhea, abdominal discomfort, headache, urinary tract infections, or genital infections. Rarely, hypoglycemia may occur when used with other antidiabetic agents.
Dapoflit VM Tablet is indicated for the management of type 2 diabetes mellitus in patients whose blood glucose levels are not adequately controlled with diet and exercise alone. It helps achieve better fasting and postprandial glycemic control as advised by a physician.
Use this medicine strictly under medical supervision. Follow the prescribed dosage and timing. Monitor blood glucose levels regularly. Caution is advised in patients with renal impairment, dehydration, or a history of recurrent infections.
Store below 25°C in a cool, dry place. Protect from moisture. Keep out of reach of children.
Composition : Atorvastatin 10mg + Aspirin 75mg + Clopidogrel 75mg Capsule
Composition : Atorvastatin (10mg) + Aspirin (75mg) Capsule
Composition : Atorvastatin Calcium I.P. 20mg + Clopidogrel I.P. 75mg + Aspirin I.P. 75mg Capsules
Composition : Atorvastatin Calcium I.P. 10mg + Clopidogrel I.P. 75mg Tablets
Composition : Atorvastatin Calcium I.P. 10mg + Aspirin I.P. 75mg Capsules
Composition : Atorvastatin Calcium I.P. 80mg Tablets
Composition : Atorvastatin Calcium I.P. 40mg Tablets
Composition : Atorvastatin Calcium I.P. 10mg Tablets
Composition : Atorvastatin Calcium I.P. 20mg Tablets
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
This triple antidiabetic combination has strong demand in the diabetes management segment, making it a high-value product for medical distributors, wholesalers, and pharma franchise partners looking to expand in the PCD pharma pharma franchise market.
Medical distributors and wholesalers can benefit from consistent demand in type 2 diabetes patients requiring multi-drug therapy for better glycemic control, especially in uncontrolled cases. It strengthens their antidiabetic and chronic care portfolio.
Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities for Dapagliflozin 10mg + Metformin 500mg SR + Vildagliptin 100mg Tablets with monopoly rights, quality packaging, competitive pricing, and reliable supply support for distributors and medical agencies.
Wholesalers and medical agencies benefit from strong chronic prescription demand, repeat sales, and stable long-term diabetes market growth when partnering with Cafoli Lifecare.
Medical distributors, stockists, wholesalers, and pharma professionals interested in this antidiabetic triple combination can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, bulk procurement, pricing details, and distribution support services.